Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …

Purpose The aim of this study was to assess the prognostic factors for treatment efficacy, and
in particular the increase in serum thyroglobulin (Tg) level at the time of the first ablative …

Purpose To evaluate the predictive capacity of clinical and laboratory variables in relation to
the success of ablation. The variables studied were as follows: thyroglobulin (Tg) in …

Background: A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after
total thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …

Purpose To investigate the clinical importance of serum thyroglobulin (Tg) levels just before
high-dose I-131 ablation therapy (preablation Tg) for predicting therapeutic failure in …

Abstract Objective To determine which Thyroglobulin (Tg) level after levothyroxine (LT4)
withdrawal (stimulated thyroglobulin-sTg) measured before radioiodine therapy (RAIT) is …

Purpose The aim of this study was to evaluate the usefulness of high-dose 131 I therapy
administered only on the basis of raised serum Tg levels. Methods Among patients treated …

Purpose We investigated whether predictive clinicopathologic factors can be affected by
different response criteria and how the clinical usefulness of radioactive iodine (RAI) therapy …

Background: In patients with differentiated thyroid cancer (DTC) and raising serum
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …

Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …